Feb 19, 2026 First Group Leaders announced for new dedicated Parkinson's Research Centre In 2025, the UK DRI partnered with Parkinson’s UK to launch a new £10m research... Learn more First Group Leaders announced for new dedicated Parkinson's Research Centre
Jan 01, 2024 Why partner with the UK DRI? The UK DRI is central to a rich and connected dementia research ecosystem, and we... Learn more Why partner with the UK DRI?
Jan 01, 2024 Why join the UK DRI? By joining the UK DRI you’ll belong to a team of world-class researchers, technical specialists... Learn more Why join the UK DRI?
Search for keywords Condition ConditionAlzheimer's diseaseFrontotemporal dementiaHuntington's diseaseLewy body dementiaMild cognitive impairmentMotor neuron disease/ALSOther conditionsParkinson's diseaseVascular dementia Techniques TechniquesAdvanced microscopy & imagingAdvanced spectroscopyBioinformaticsBiophysical techniquesCRISPRDrug screeningElectrophysiologyEpigenomicsExperimental medicineFlow cytometryFluid biomarkersGenomicsHuman brain imagingLipidomicsMass spec-based proteomicsMetabolomicsMouse behaviourMouse in vivo imagingNext generation sequencingNon-mammalian animal modelsOptogeneticsRobotics & environmental sensingSingle cell / nucleus transcriptomicsSoftware developmentSpatial transcriptomicsStatistical modellingStem cells / iPSCsStructural biologyTranscranial brain stimulationViral-mediated expression Topic TopicAgeingBiomarkers & diagnosticsCare & Home technologyCell biology of neurons & gliaGeneticsImmune systemLifestyle & environmentMolecular mechanismsSleep & Circadian rhythmsSynapse & CircuitryTreatments & InterventionsVascular system Dr Tom Massey Group Leader UK DRI at Cardiff Using recent genetic discoveries to develop new drug targets for Huntington's disease Learn more Dr Tom Massey Dr Mireia Mato Prado Lab Manager Learn more Dr Mireia Mato Prado Prof Paul Matthews Group Leader UK DRI at Imperial Exploring neuronal vulnerability and genetic risk variants in Alzheimer’s progression Learn more Prof Paul Matthews Katja McBane Research Assistant Learn more Katja McBane Dr Barry McColl Group Leader UK DRI at Edinburgh Investigating the role of microglia in neurodegenerative disease Learn more Dr Barry McColl Dr Will McEwan Group Leader UK DRI at Cambridge Deciphering the mechanisms of tau accumulation and exploring new methods for treatment of tauopathies Learn more Dr Will McEwan Dr John McFadden Postdoctoral Researcher Learn more Dr John McFadden Dr Robert (Rob) McGeachan Postdoctoral Researcher Learn more Dr Robert (Rob) McGeachan Dr Sarah McGlasson Postdoctoral Researcher Learn more Dr Sarah McGlasson Dr Charlie McKechnie Clinical Research Fellow Learn more Dr Charlie McKechnie Anna McKeever PhD student Learn more Anna McKeever Constance McManus Research Assistant Learn more Constance McManus Pagination First page First Previous page ‹ … Page 55 Page 56 Current page 57 Page 58 Page 59 … Next page › Last page Last
Dr Tom Massey Group Leader UK DRI at Cardiff Using recent genetic discoveries to develop new drug targets for Huntington's disease Learn more Dr Tom Massey
Prof Paul Matthews Group Leader UK DRI at Imperial Exploring neuronal vulnerability and genetic risk variants in Alzheimer’s progression Learn more Prof Paul Matthews
Dr Barry McColl Group Leader UK DRI at Edinburgh Investigating the role of microglia in neurodegenerative disease Learn more Dr Barry McColl
Dr Will McEwan Group Leader UK DRI at Cambridge Deciphering the mechanisms of tau accumulation and exploring new methods for treatment of tauopathies Learn more Dr Will McEwan
